p-Cresyl sulfate production pathway

p-Cresyl sulfate (PCS) production is a multi-step metabolic process involving both gut microbiota and host hepatic enzymes, resulting in the formation of a potent uremic toxin. The pathway begins in the colon, where anaerobic bacteria ferment the aromatic amino acid tyrosine into p-cresol (Gryp et al., 2017). Once absorbed into the portal circulation, p-cresol undergoes hepatic conjugation, primarily sulfation by sulfotransferases such as SULT1A1, to form p-cresyl sulfate (Teubner et al., 2007). In healthy individuals, PCS is cleared by the kidneys via tubular secretion; however, in patients with chronic kidney disease (CKD), it accumulates significantly due to reduced renal clearance. Elevated levels of PCS are associated with systemic inflammation, oxidative stress, and increased cardiovascular mortality in the CKD population (Saito et al., 2014). Therapeutic strategies targeting PCS production include oral adsorbents like AST-120, which sequester p-cresol in the gut, as well as dietary interventions and microbiome modulation to reduce the precursor load (Meijers et al., 2010).

Other names

p-Cresol sulfationp-Cresyl sulfate biosynthesisMicrobial p-cresol metabolismp-Cresyl sulfate synthesis

Adsorption of p-cresol in the gastrointestinal tract to prevent systemic absorption and subsequent hepatic sulfation; modulation of gut microbiota to reduce bacterial tyrosine fermentation.